.Amgen has shared (PDF) the very first stage 3 records on its $400 thousand eczema medication, linki...
.Biogen and UCB's depend advancing into period 3 on the back of a failed research looks to have paid...
.Italian biotech Aptadir Rehabs has released with the commitment that its own pipe of preclinical RN...
.Surge Life Sciences has actually fulfilled its own target in a Duchenne muscle dystrophy (DMD) rese...
.After a few years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma crease, usin...
.Achilles Therapies has actually shreded its tactic. The English biotech is knocking off on its own ...
.Aligos Therapies is actually heralding a midstage win in metabolic-dysfunction connected steatohepa...
.Basilea Pharmaceutica's job developing brand new antifungals has received a considerable increase c...
.Possessing already scooped up the U.S. liberties to Capricor Therapeutics' late-stage Duchenne musc...
.After dismissing the decision meeting for Applied Rehabs' metabolic disorder medicine govorestat, t...